key: cord-1009877-14itu1qq
authors: Li, Yi-Heng; Wang, Mei-Tzu; Huang, Wei-Chun; Hwang, Juey-Jen
title: Reply to Letter to the Editor Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19pandemic
date: 2020-08-20
journal: J Formos Med Assoc
DOI: 10.1016/j.jfma.2020.08.005
sha: b82e0e7c182a9ae3f8a2000ff88dc17cbc21f10f
doc_id: 1009877
cord_uid: 14itu1qq

nan

We thank Dr. Chia Siang Kow for their letter about our recent publication of the consensus for management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019 in Taiwan. 1 We completely agree with the point they indicated in the letter that primary percutaneous coronary intervention (PCI) is preferred to fibrinolytic therapy as the reperfusion strategy for ST-elevation myocardial infarction (STEMI). In fact, in the recently published 2020

Taiwan STEMI guideline, 2 we recommended all STEMI patients in Taiwan to receive primary PCI because of the well-organized hospital system for 24-hour primary PCI and convenient traffic system for transportation in Taiwan. However, fibrinolysis is still recommended in some special occasions, such as during severe pandemic infectious diseases or in adjacent small islands without PCI available hospitals. 2 The previous invasion of severe acute respiratory syndrome (SARS) from China to Taiwan in 2003 caused intrahospital cluster cases of infection and shut-down some of the major hospitals in Taiwan. Rapid reperfusion with primary PCI becomes exceedingly difficult if the similar events occur again during the COVID-19 pandemic. Therefore, based on the experience of SARS, our consensus suggests that fibrinolytic therapy could be considered before primary PCI if there is concern of nosocomial viral transmission. However, we are not saying that primary PCI cannot be performed. Our consensus recommends that primary PCI can be performed if adequate personnel protection can be maintained during intervention and regulations be followed 

Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology

2020 focused update of the 2012 guidelines of the Taiwan Society of Cardiology for the management of ST-segment elevation myocardial infarction

A locally transmitted case of SARS-CoV-2 infection in Taiwan

No reduction of ST-segment elevation myocardial infarction admission in Taiwan during coronavirus pandemic